Price of glenmark pharma

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the India, North America, Latin America, Europe, and Rest of the World geographical segments. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India. Glenmark Pharma has completed a long-term inverted Head & shoulders pattern. It is now looking bullish with an upside move of INR 500 from current levels. Almost 2x. At present it is at the 0.5 resistance level of the Fibonacci chart Glenmark Pharma has completed a long-term inverted Head & shoulders pattern. It is now looking bullish with an upside move of INR 500 from current levels. Almost 2x. At present it is at the 0.5 resistance level of the Fibonacci chart One can accumulate this in range of 550-650 with the Sl Of ₹490 and Target of 950 and 1050 good breakout can be seen on a quaterly chart.. lets see if it sustains One can accumulate this in range of 550-650 with the Sl Of ₹490 and Target of 950 and 1050 good breakout can be seen on a quaterly chart.. lets see if it sustains In Gujarati “ Bhav is Bhagwan ” Disclaimer : I am not a SEBI registered Analyst. Please do your own Analysis before taking any trade/investment. The above view is just for educational purpose only. In Gujarati “ Bhav is Bhagwan ” Disclaimer : I am not a SEBI registered Analyst. Please do your own Analysis before taking any trade/investment. Th...

Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 8141.58 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2022.